Windtree Therapeutics Stock Market Value
| WINT Stock | USD 0.56 0.06 12.00% |
| Symbol | Windtree |
Windtree Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Windtree Therapeutics. If investors know Windtree will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.03) | Quarterly Revenue Growth (1.00) | Return On Assets (0.45) | Return On Equity (1.51) |
The market value of Windtree Therapeutics is measured differently than its book value, which is the value of Windtree that is recorded on the company's balance sheet. Investors also form their own opinion of Windtree Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Windtree Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Windtree Therapeutics' market value can be influenced by many factors that don't directly affect Windtree Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Windtree Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Windtree Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Windtree Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Windtree Therapeutics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Windtree Therapeutics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Windtree Therapeutics or generate 0.0% return on investment in Windtree Therapeutics over 30 days. Windtree Therapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for ... More
Windtree Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Windtree Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Windtree Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 62.78 | |||
| Value At Risk | (18.48) | |||
| Potential Upside | 12.0 |
Windtree Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Windtree Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Windtree Therapeutics' standard deviation. In reality, there are many statistical measures that can use Windtree Therapeutics historical prices to predict the future Windtree Therapeutics' volatility.| Risk Adjusted Performance | (0.20) | |||
| Jensen Alpha | (3.93) | |||
| Total Risk Alpha | (5.36) | |||
| Treynor Ratio | (0.84) |
Windtree Therapeutics Backtested Returns
Windtree Therapeutics shows Sharpe Ratio of -0.26, which attests that the company had a -0.26% return per unit of risk over the last 3 months. Windtree Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Windtree Therapeutics' Standard Deviation of 12.4, mean deviation of 7.39, and Market Risk Adjusted Performance of (0.83) to validate the risk estimate we provide. The firm maintains a market beta of 4.12, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Windtree Therapeutics will likely underperform. At this point, Windtree Therapeutics has a negative expected return of -3.33%. Please make sure to check out Windtree Therapeutics' total risk alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Windtree Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Windtree Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Windtree Therapeutics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Windtree Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Windtree Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Windtree Therapeutics lagged returns against current returns
Autocorrelation, which is Windtree Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Windtree Therapeutics' stock expected returns. We can calculate the autocorrelation of Windtree Therapeutics returns to help us make a trade decision. For example, suppose you find that Windtree Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Windtree Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Windtree Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Windtree Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Windtree Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Windtree Therapeutics Lagged Returns
When evaluating Windtree Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Windtree Therapeutics stock have on its future price. Windtree Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Windtree Therapeutics autocorrelation shows the relationship between Windtree Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Windtree Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.